2nd Annual EVIDENCE 360: RWE, Pricing & Market Access Summit

UK Edition 2026

As healthcare systems worldwide shift toward value-based decision-making, Real World Evidence (RWE) has become a critical driver of regulatory approval, pricing strategy, and market access success. To address these evolving needs, the 2nd Annual EVIDENCE 360: RWE, Pricing & Market Access Summit (EVIDENCE360-UK) returns to London on March 16–17, 2026, bringing together global experts shaping the future of evidence-led healthcare.

Organized by Veridon Global, this two-day, in-person conference is designed for senior professionals across pharmaceuticals, biotechnology, healthcare organizations, payers, and regulatory bodies.

Why EVIDENCE 360 Matters in 2026

The healthcare ecosystem is under increasing pressure to demonstrate clinical value, economic impact, and patient-centric outcomes. Traditional clinical trial data alone is no longer sufficient. Decision-makers now rely on integrated Real World Data (RWD) and RWE frameworks to support:

• Pricing and reimbursement decisions
• Market access strategies
• Health Technology Assessments (HTA)
• Post-marketing surveillance and drug safety
• Regulatory and payer engagement

EVIDENCE 360 provides a focused platform to explore how RWE and HEOR are transforming evidence generation across the product lifecycle.

Key Themes and Focus Areas

The 2026 UK edition will cover practical, forward-looking insights across:

• Real World Evidence Strategy & Data Generation
• Health Economics & Outcomes Research (HEOR)
• Pricing, Reimbursement & Market Access Innovation
• Regulatory and HTA Expectations
• Patient-Centric Evidence & Outcomes Research
• Pharmacovigilance & Drug Safety
• Healthcare Data Analytics, AI & Digital Health

Through keynote presentations, expert-led panel discussions, and interactive workshops, attendees will gain actionable strategies directly applicable to real-world challenges.

Who Should Attend?

This summit is ideal for professionals working in:

• Pharmaceutical & Biopharmaceutical Companies
• Biotechnology Organizations
• Market Access & Pricing Teams
• HEOR & RWE Leaders
• Regulatory Affairs & Policy Experts
• Pharmacovigilance & Drug Safety Teams
• Healthcare Analytics & Outcomes Research

The conference also offers valuable networking opportunities with global decision-makers, regulators, and industry innovators.

Event Details at a Glance

• Event: 2nd Annual EVIDENCE 360: RWE, Pricing & Market Access Summit
• Short Name: EVIDENCE360-UK
• Dates: March 16–17, 2026
• Format: Physical / In-Person Conference
• Location: London, United Kingdom
• Venue: Millennium Hotel and Conference Centre Gloucester, London
• Organizer: Veridon Global

Join the Conversation Shaping Evidence-Led Healthcare

As regulatory expectations rise and payer scrutiny intensifies, the ability to translate real-world data into meaningful evidence has never been more important. EVIDENCE 360: RWE, Pricing & Market Access Summit 2026 offers a unique opportunity to stay ahead of industry trends, align with global best practices, and strengthen evidence-driven decision-making.

📍 Learn more and register: https://realworldevidenceconference.com/upcoming-conferences/uk-edition/registration/